National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 39277 [2016-14195]
Download as PDF
Federal Register / Vol. 81, No. 116 / Thursday, June 16, 2016 / Notices
Contact Person: David I. Sommers, Ph.D.,
Scientific Review, Officer Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892–9606, 301–443–7861
dsommers@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: June 10, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–14197 Filed 6–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Joint meeting of the
National Cancer Advisory Board and
NCI Board of Scientific Advisors, June
20, 2016, 04:30 p.m. to June 21, 2016,
05:30 p.m., National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
6th Floor, Conference Room 10,
Bethesda, MD, 20892 which was
published in the Federal Register on
May 16, 2016, 81 FR 30316.
This meeting is being amended to
change the start time of the open session
on June 21, 2016 from 8:00 a.m. to 8:30
a.m. The meeting is partially closed to
the public.
Dated: June 9, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–14193 Filed 6–15–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
18:04 Jun 15, 2016
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Human Immunology Project
Consortium.
Date: July 13–20, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
Ballroom A,B,C, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G41, NIAID/NIH/DHHS, 5601 Fishers
Lane, Bethesda, MD 20892–7616, 240–669–
5067, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 10, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–14195 Filed 6–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
New Date for the October 2016
Customs Broker License Examination
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces
that U.S. Customs and Border Protection
has changed the date on which the
semi-annual written examination for an
individual broker’s license will be held
in October 2016.
DATES: The customs broker’s license
examination scheduled for October 2016
will be held on Wednesday, October 5.
FOR FURTHER INFORMATION CONTACT: John
Lugo, Broker Management Branch,
Office of Trade, (202) 863–6015.
SUPPLEMENTARY INFORMATION:
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Jkt 238001
Background
Section 641 of the Tariff Act of 1930,
as amended (19 U.S.C. 1641), provides
that a person (an individual,
corporation, association, or partnership)
must hold a valid customs broker’s
license and permit in order to transact
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
39277
customs business on behalf of others,
sets forth standards for the issuance of
broker’s licenses and permits, and
provides for the taking of disciplinary
action against brokers that have engaged
in specified types of infractions. This
section also provides that an
examination may be conducted to assess
an applicant’s qualifications for a
license.
The regulations issued under the
authority of section 641 are set forth in
Title 19 of the Code of Federal
Regulations, part 111 (19 CFR 111). Part
111 sets forth the regulations regarding
the licensing of, and granting of permits
to, persons seeking to transact customs
business as customs brokers. These
regulations also include the
qualifications required of applicants and
the procedures for applying for licenses
and permits. 19 CFR 111.11 sets forth
the basic requirements for a broker’s
license and, in 19 CFR 111.11(a)(4),
provides that an applicant for an
individual broker’s license must attain a
passing grade (75 percent or higher) on
a written examination.
19 CFR 111.13 sets forth the
requirements and procedures for the
written examination for an individual
broker’s license and states that written
customs broker license examinations
will be given on the first Monday in
April and October unless the regularly
scheduled examination date conflicts
with a national holiday, religious
observance, or other foreseeable event.
CBP recognizes that the first Monday
in October 2016 coincides with the
observance of the religious holiday of
Rosh Hashanah. In consideration of this
conflict, CBP has decided to change the
regularly scheduled date of the
examination. This document announces
that CBP has scheduled the October
2016 broker license examination for
Wednesday, October 5, 2016.
Dated: June 6, 2016.
Brenda B. Smith,
Executive Assistant Commissioner, Office of
Trade.
[FR Doc. 2016–14215 Filed 6–15–16; 8:45 am]
BILLING CODE 9111–14–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–16–021]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: June 24, 2016 at 11:00
a.m.
AGENCY HOLDING THE MEETING:
E:\FR\FM\16JNN1.SGM
16JNN1
Agencies
[Federal Register Volume 81, Number 116 (Thursday, June 16, 2016)]
[Notices]
[Page 39277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14195]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Human Immunology Project
Consortium.
Date: July 13-20, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, Ballroom A,B,C, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Amstad, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G41, NIAID/NIH/DHHS, 5601 Fishers Lane, Bethesda,
MD 20892-7616, 240-669-5067, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 10, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-14195 Filed 6-15-16; 8:45 am]
BILLING CODE 4140-01-P